Susquehanna International Group, LLP Nektar Therapeutics Put Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $61,712 - $104,342	-20,300 Reduced 66.56%	10,200 $33,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $2.09 Million - $4.07 Million	-660,000 Reduced 95.58%	30,500 $116,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $2.56 Million - $8.43 Million	614,200 Added 804.98%	690,500 $3.72 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $354,141 - $602,007	-32,700 Reduced 30.0%	76,300 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $2.21 Million - $3.19 Million	-169,400 Reduced 60.85%	109,000 $1.96 Million

Q2 2021 Aug 11, 2021	BUY	$16.52 - $20.4 $3.23 Million - $3.99 Million	195,800 Added 237.05%	278,400 $4.78 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $114,263 - $175,674	-6,900 Reduced 7.71%	82,600 $1.65 Million
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $544,065 - $656,535	-34,500 Reduced 27.82%	89,500 $1.52 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $439,635 - $656,935	-26,500 Reduced 17.61%	124,000 $2.06 Million
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $485,568 - $675,072	28,800 Added 23.66%	150,500 $3.49 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $5.38 Million - $10.4 Million	-371,800 Reduced 75.34%	121,700 $2.17 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $4.58 Million - $6.67 Million	-288,700 Reduced 36.91%	493,500 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $5.37 Million - $11.5 Million	-317,700 Reduced 28.88%	782,200 $14.2 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $5.25 Million - $6.15 Million	169,500 Added 18.22%	1,099,900 $39.1 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $4.87 Million - $7.14 Million	154,100 Added 19.85%	930,400 $31.3 Million
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $66,946 - $124,630	-2,200 Reduced 0.28%	776,300 $25.5 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $7.28 Million - $10.7 Million	-156,600 Reduced 16.75%	778,500 $47.5 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $12.5 Million - $28.3 Million	270,800 Added 40.76%	935,100 $45.7 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $27.3 Million - $51.6 Million	476,000 Added 252.79%	664,300 $70.6 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $515,648 - $1.36 Million	22,400 Added 13.5%	188,300 $11.2 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $2.95 Million - $3.98 Million	165,900	165,900 $3.98 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$23.7 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$15.5 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$9.76 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.99 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$7.58 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account